The global corneal implant market was valued at $1.26 Billion in 2021, and is projected to reach $2.12 Billion by 2031, registering a CAGR of 5.3% from 2022 to 2031.
The outermost translucent portion of the eyeball's covering known as the cornea protects the iris and pupil while allowing light to enter the interior. It directs and concentrates light as it enters the eye. Between 65 and 75 percent of the eye's entire focusing power comes from the cornea.
A corneal transplant involves replacing a cloudy cornea with a clear donor cornea. Donor tissue comes from individuals who have donated their eyes for the benefit of others. The donor corneas used in transplants are kept freshly stored in eye banks. Furthermore, artificial cornea is an option for transplant patients who cannot tolerate a human donor cornea. In order to correct vision issues caused by various ocular disorders, corneal transplants are typically performed.
The global corneal implant market is expected to witness a substantial growth in the future, owing to surge in prevalence of eye diseases such as Fuchs’ dystrophy, keratoconus keratitis, corneal scarring, corneal ulcers and corneal edema. People suffering from these ocular diseases need corneal transplantation on the basis of severity of diseases.
Furthermore, rise in incidences of corneal blindness is the primary factor that drives the growth of the cornea implant market. For instance, according to the SightLife organization more than 12.7 million people globally suffer from corneal blindness. Thus, rise in incidences of corneal blindness is the primary factor that drives the growth of the cornea implant market. In addition, increase in incidences of trauma cases lead to high chances of eye injury, which further propel the market growth.
Moreover, technological advancements in the development of the artificial cornea propel the market growth. Various key market players are involved in the development of the bioengineered artificial corneal implant which further drives the demand of the corneal implants subsequently flourish the market growth.
Furthermore, growth opportunities in emerging markets contribute towards the growth of the market. Availability of improved healthcare industry infrastructure, growth in number of pharmaceutical industries, and surge in incidence of the corneal disorders drives the growth of the market in emerging economies. However, low availability of human cornea donors and high risk in the grafting artificial cornea implant is expected to impede the market growth during the forecast period. Conversely, rise in geriatric population is a lucrative opportunity for the market growth. As the geriatric population is more susceptible to corneal diseases.
The global corneal implant market is segmented into type, disease type, transplant type, end user, and region. On the basis of disease type, the market is segregated into keratoconus, Fuchs’ dystrophy, infectious keratitis and others. On the basis of transplant type, market is segmented into penetrating keratoplasty, anterior lamellar keratoplasty, endothelial keratoplasty and keratoprothesis. On the basis of end user, the market is categorized into hospitals, ambulatory surgical centers and ophthalmic centers. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global corneal implant market are Corneagen, Presbia Plc, Presbia Plc, mediphacos, Aurolab, AJL Opthalmic SA, LinkoCare Life Sciences AB, DIOPTEX, EyeYon Medical, and KeraMed, Inc.
The outermost translucent portion of the eyeball's covering known as the cornea protects the iris and pupil while allowing light to enter the interior. It directs and concentrates light as it enters the eye. Between 65 and 75 percent of the eye's entire focusing power comes from the cornea.
A corneal transplant involves replacing a cloudy cornea with a clear donor cornea. Donor tissue comes from individuals who have donated their eyes for the benefit of others. The donor corneas used in transplants are kept freshly stored in eye banks. Furthermore, artificial cornea is an option for transplant patients who cannot tolerate a human donor cornea. In order to correct vision issues caused by various ocular disorders, corneal transplants are typically performed.
The global corneal implant market is expected to witness a substantial growth in the future, owing to surge in prevalence of eye diseases such as Fuchs’ dystrophy, keratoconus keratitis, corneal scarring, corneal ulcers and corneal edema. People suffering from these ocular diseases need corneal transplantation on the basis of severity of diseases.
Furthermore, rise in incidences of corneal blindness is the primary factor that drives the growth of the cornea implant market. For instance, according to the SightLife organization more than 12.7 million people globally suffer from corneal blindness. Thus, rise in incidences of corneal blindness is the primary factor that drives the growth of the cornea implant market. In addition, increase in incidences of trauma cases lead to high chances of eye injury, which further propel the market growth.
Moreover, technological advancements in the development of the artificial cornea propel the market growth. Various key market players are involved in the development of the bioengineered artificial corneal implant which further drives the demand of the corneal implants subsequently flourish the market growth.
Furthermore, growth opportunities in emerging markets contribute towards the growth of the market. Availability of improved healthcare industry infrastructure, growth in number of pharmaceutical industries, and surge in incidence of the corneal disorders drives the growth of the market in emerging economies. However, low availability of human cornea donors and high risk in the grafting artificial cornea implant is expected to impede the market growth during the forecast period. Conversely, rise in geriatric population is a lucrative opportunity for the market growth. As the geriatric population is more susceptible to corneal diseases.
The global corneal implant market is segmented into type, disease type, transplant type, end user, and region. On the basis of disease type, the market is segregated into keratoconus, Fuchs’ dystrophy, infectious keratitis and others. On the basis of transplant type, market is segmented into penetrating keratoplasty, anterior lamellar keratoplasty, endothelial keratoplasty and keratoprothesis. On the basis of end user, the market is categorized into hospitals, ambulatory surgical centers and ophthalmic centers. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global corneal implant market are Corneagen, Presbia Plc, Presbia Plc, mediphacos, Aurolab, AJL Opthalmic SA, LinkoCare Life Sciences AB, DIOPTEX, EyeYon Medical, and KeraMed, Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the corneal implants market analysis from 2021 to 2031 to identify the prevailing corneal implants market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the corneal implants market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global corneal implants market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Procedure Type
- Penetrating keratoplasty
- Endothelial keratoplasty
- Others
By Disease Type
- Keratoconus
- Fuchs' dystrophy
- Infectious keratitis
- Others
By End User
- Hospitals
- Ophthalmic centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Presbia Plc
- CorNeat Vision
- Aurolab
- AJL Opthalmic SA
- LinkoCare Life Sciences AB
- CorneaGen
- DIOPTEX
- Mediphacos
- EyeYon Medical
- KeraMed, Inc
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE
CHAPTER 5: CORNEAL IMPLANTS MARKET, BY DISEASE TYPE
CHAPTER 6: CORNEAL IMPLANTS MARKET, BY END USER
CHAPTER 7: CORNEAL IMPLANTS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Presbia Plc
- CorNeat Vision
- Aurolab
- AJL Opthalmic SA
- LinkoCare Life Sciences AB
- CorneaGen
- DIOPTEX
- Mediphacos
- EyeYon Medical
- KeraMed, Inc
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
